Omics-based analysis of mitochondrial dysfunction and BBB integrity in post-COVID-19 sequelae.

Area of Science:

• Neuroscience
• Virology
• Immunology

Background:

• The SARS-CoV-2 virus, responsible for COVID-19, is linked to neurological complications like encephalopathy and cognitive decline.
• Blood-brain barrier (BBB) integrity is vital for brain function, and its disruption is a suspected factor in COVID-19-related neurological issues.

Purpose of the Study:

• To investigate the neurological impacts of SARS-CoV-2.
• To elucidate the molecular mechanisms underlying BBB breakdown and neurological symptoms in COVID-19 patients.

Main Methods:

• Analysis of multi-transcriptome data from COVID-19 patients.
• Exploration of gene expression in BBB endothelial cells.
• Identification of pathways related to oxidative stress and mitochondrial dysfunction.

Main Results:

• SARS-CoV-2 infection induces systemic inflammation, leading to inflammatory gene expression in BBB endothelial cells.
• Oxidative stress and endothelial cell activation play roles in SARS-CoV-2 crossing the BBB, promoting inflammation and neurological disorders.
• Mitochondrial dysfunction in SARS-CoV-2 infection causes reactive oxygen species accumulation, endothelial dysfunction, and BBB permeability.

Conclusions:

• Systemic inflammation caused by SARS-CoV-2 correlates with BBB integrity.
• Mitochondrial dysfunction and oxidative stress are key contributors to COVID-19-related neurological complications.
• Targeting inflammation and BBB dysfunction biomarkers may offer novel therapeutic strategies for COVID-19 neurological sequelae.